Rubius Therapeutics Inc (NASDAQ:RUBY)

5.05
BATS BZX Real-Time Price
As of 1:42pm ET
 +0.05 / +1.00%
Today’s Change
3.35
Today|||52-Week Range
14.44
-46.84%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 7.00, with a high estimate of 28.00 and a low estimate of 3.00. The median estimate represents a +38.61% increase from the last price of 5.05.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Rubius Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.49
Sales
$0.00
Reporting Date
Aug 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.33%
 
 
 
 
 
 
Growthannually 6.25%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.